Luan, Xiaoyi
Han, Xue
Wang, Zerong
Zhao, Lulu
Zhang, Xiaojie
Wang, Wanqing
Niu, Penghui
Wang, Danjun
Zhao, Dongbing
Zhu, Mingwei
Chen, Yingtai
Funding for this research was provided by:
National Key R&D Program of China (2017YFC0908300, 2017YFC0908300, 2017YFC0908300, 2017YFC0908300, 2017YFC0908300, 2017YFC0908300, 2017YFC0908300, 2017YFC0908300, 2017YFC0908300, 2017YFC0908300)
Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2021-RC310-009, 2021-RC310-009, 2021-RC310-009, 2021-RC310-009, 2021-RC310-009, 2021-RC310-009, 2021-RC310-009, 2021-RC310-009, 2021-RC310-009, 2021-RC310-009)
Article History
Received: 13 April 2025
Accepted: 24 July 2025
First Online: 8 August 2025
Declarations
:
: Not applicable.
: The authors declare no competing interests.
: The authors take full responsibility for ensuring the validity and integrity of this research, including the thorough investigation and resolution of any issues pertaining to the study. The study was carried out in compliance with the ethical principles outlined in the Declaration of Helsinki, and ethical approval was obtained from the Institutional Review Board of the National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College (Approval No. 17–156/1412). Due to the anonymous nature of the clinical data, informed consent requirements were waived by the Institutional Review Board of National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College.